CAM
JAZZ icon

Centre Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Centre Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$8.78M Sell
70,692
-5,111
-7% -$667K 2.26% 15
2024
Q4 		$9.34M Buy
+75,803
New +$8.93M 2.14% 21
2024
Q2 		– Sell
-70,381
Closed -$8.47M – 65
2024
Q1 		$8.47M Buy
+70,381
New +$8.62M 2.02% 26

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Centre Asset Management's JAZZ Position: Q1 2025 in Review

Centre Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.7% in Q1 2025, selling an estimated $667K and leaving 70,692 shares worth $8.78M. The position accounts for 2.26% of the portfolio, ranked #15.

Centre Asset Management first reported a position in JAZZ in Q1 2024 and has held it in 3 quarters since. The position peaked at $9.34M in Q4 2024. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Centre Asset Management held 70,692 shares of Jazz Pharmaceuticals worth $8.78M as of Q1 2025.
  • Centre Asset Management sold 5,111 Jazz Pharmaceuticals shares in Q1 2025, an estimated $667K.
  • Jazz Pharmaceuticals made up 2.26% of Centre Asset Management's portfolio in Q1 2025, its #15 holding.
  • Centre Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • Centre Asset Management's Jazz Pharmaceuticals position peaked at $9.34M in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Centre Asset Management's 13F filing for Q1 2025, filed 1 Apr 2025.